165 related articles for article (PubMed ID: 9555869)
1. Lysophosphatidylcholine is involved in the antigenicity of oxidized LDL.
Wu R; Huang YH; Elinder LS; Frostegård J
Arterioscler Thromb Vasc Biol; 1998 Apr; 18(4):626-30. PubMed ID: 9555869
[TBL] [Abstract][Full Text] [Related]
2. Antibodies against lysophosphatidylcholine and oxidized LDL in patients with SLE.
Wu R; Svenungsson E; Gunnarsson I; Andersson B; Lundberg I; Schäfer Elinder L; Frostegård J
Lupus; 1999; 8(2):142-50. PubMed ID: 10192509
[TBL] [Abstract][Full Text] [Related]
3. Antibodies to adult human endothelial cells cross-react with oxidized low-density lipoprotein and beta 2-glycoprotein I (beta 2-GPI) in systemic lupus erythematosus.
Wu R; Svenungsson E; Gunnarsson I; Haegerstrand-Gillis C; Andersson B; Lundberg I; Elinder LS; Frostegård J
Clin Exp Immunol; 1999 Mar; 115(3):561-6. PubMed ID: 10193434
[TBL] [Abstract][Full Text] [Related]
4. Comparative toxicity of oxidatively modified low-density lipoprotein and lysophosphatidylcholine in cultured vascular endothelial cells.
Naito M; Yamada K; Hayashi T; Asai K; Yoshimine N; Iguchi A
Heart Vessels; 1994; 9(4):183-7. PubMed ID: 7961295
[TBL] [Abstract][Full Text] [Related]
5. Short- and long-term elevation of autoantibody titers against oxidized LDL in patients with acute coronary syndromes. Role of the lipoprotein-associated phospholipase A2 and the effect of atorvastatin treatment.
Papathanasiou AI; Lourida ES; Tsironis LD; Goudevenos JA; Tselepis AD
Atherosclerosis; 2008 Jan; 196(1):289-297. PubMed ID: 17140582
[TBL] [Abstract][Full Text] [Related]
6. The low-density lipoprotein (LDL)-associated PAF-acetylhydrolase activity and the extent of LDL oxidation are important determinants of the autoantibody titers against oxidized LDL in patients with coronary artery disease.
Lourida ES; Papathanasiou AI; Goudevenos JA; Tselepis AD
Prostaglandins Leukot Essent Fatty Acids; 2006 Aug; 75(2):117-26. PubMed ID: 16843649
[TBL] [Abstract][Full Text] [Related]
7. Lysophosphatidylcholine (LPC) induces proinflammatory cytokines by a platelet-activating factor (PAF) receptor-dependent mechanism.
Huang YH; Schäfer-Elinder L; Wu R; Claesson HE; Frostegård J
Clin Exp Immunol; 1999 May; 116(2):326-31. PubMed ID: 10337026
[TBL] [Abstract][Full Text] [Related]
8. High plasma immunoglobulin (Ig) A and low IgG antibody titers to oxidized low-density lipoprotein are associated with markers of glucose metabolism.
Sämpi M; Veneskoski M; Ukkola O; Kesäniemi YA; Hörkkö S
J Clin Endocrinol Metab; 2010 May; 95(5):2467-75. PubMed ID: 20332251
[TBL] [Abstract][Full Text] [Related]
9. Antibodies against various forms of mildly oxidized low-density lipoprotein are not associated with carotid intima-media thickness in patients with primary hyperlipidemia.
Tsouli SG; Kiortsis DN; Xydis V; Argyropoulou MI; Elisaf M; Tselepis AD
Angiology; 2006; 57(5):615-22. PubMed ID: 17067985
[TBL] [Abstract][Full Text] [Related]
10. Percutaneous coronary intervention results in acute increases in oxidized phospholipids and lipoprotein(a): short-term and long-term immunologic responses to oxidized low-density lipoprotein.
Tsimikas S; Lau HK; Han KR; Shortal B; Miller ER; Segev A; Curtiss LK; Witztum JL; Strauss BH
Circulation; 2004 Jun; 109(25):3164-70. PubMed ID: 15184281
[TBL] [Abstract][Full Text] [Related]
11. Oxidized low-density lipoprotein and beta2-glycoprotein I in patients with systemic lupus erythematosus and increased carotid intima-media thickness: implications in autoimmune-mediated atherosclerosis.
Lopez LR; Salazar-Paramo M; Palafox-Sanchez C; Hurley BL; Matsuura E; Garcia-De La Torre I
Lupus; 2006; 15(2):80-6. PubMed ID: 16539278
[TBL] [Abstract][Full Text] [Related]
12. Autoantibodies against oxidized low density lipoproteins (oxLDL): characterization of antibody isotype, subclass, affinity and effect on the macrophage uptake of oxLDL.
Wu R; Lefvert AK
Clin Exp Immunol; 1995 Oct; 102(1):174-80. PubMed ID: 7554386
[TBL] [Abstract][Full Text] [Related]
13. Temporal increases in plasma markers of oxidized low-density lipoprotein strongly reflect the presence of acute coronary syndromes.
Tsimikas S; Bergmark C; Beyer RW; Patel R; Pattison J; Miller E; Juliano J; Witztum JL
J Am Coll Cardiol; 2003 Feb; 41(3):360-70. PubMed ID: 12575961
[TBL] [Abstract][Full Text] [Related]
14. Oxidized low-density lipoprotein autoantibodies, chronic infections, and carotid atherosclerosis in a population-based study.
Mayr M; Kiechl S; Tsimikas S; Miller E; Sheldon J; Willeit J; Witztum JL; Xu Q
J Am Coll Cardiol; 2006 Jun; 47(12):2436-43. PubMed ID: 16781371
[TBL] [Abstract][Full Text] [Related]
15. Auto-Antibody Production During Experimental Atherosclerosis in
Hutchinson MA; Park HS; Zanotti KJ; Alvarez-Gonzalez J; Zhang J; Zhang L; Telljohann R; Wang M; Lakatta EG; Gearhart PJ; Maul RW
Front Immunol; 2021; 12():695220. PubMed ID: 34305930
[TBL] [Abstract][Full Text] [Related]
16. Oxidative modification of low-density lipoproteins and the inhibition of relaxations mediated by endothelium-derived nitric oxide in rabbit aorta.
Plane F; Bruckdorfer KR; Kerr P; Steuer A; Jacobs M
Br J Pharmacol; 1992 Jan; 105(1):216-22. PubMed ID: 1596684
[TBL] [Abstract][Full Text] [Related]
17. Anti-oxLDL antibody isotype levels, as potential markers for progressive atherosclerosis in APOE and APOECD40L mice.
Smook ML; van Leeuwen M; Heeringa P; Damoiseaux JG; Theunissen R; Daemen MJ; Lutgens E; Tervaert JW
Clin Exp Immunol; 2008 Nov; 154(2):264-9. PubMed ID: 18778362
[TBL] [Abstract][Full Text] [Related]
18. Antibodies to oxidized LDL and LDL-containing immune complexes as risk factors for coronary artery disease in diabetes mellitus.
Lopes-Virella MF; Virella G; Orchard TJ; Koskinen S; Evans RW; Becker DJ; Forrest KY
Clin Immunol; 1999 Feb; 90(2):165-72. PubMed ID: 10080827
[TBL] [Abstract][Full Text] [Related]
19. Cross-reactive saliva IgA antibodies to oxidized LDL and periodontal pathogens in humans.
Akhi R; Wang C; Kyrklund M; Kummu O; Turunen SP; Hyvärinen K; Kullaa A; Salo T; Pussinen PJ; Hörkkö S
J Clin Periodontol; 2017 Jul; 44(7):682-691. PubMed ID: 28548243
[TBL] [Abstract][Full Text] [Related]
20. Increased levels of autoantibodies against copper-oxidized low density lipoprotein, malondialdehyde-modified low density lipoprotein and cardiolipin in patients with rheumatoid arthritis.
Cvetkovic JT; Wållberg-Jonsson S; Ahmed E; Rantapää-Dahlqvist S; Lefvert AK
Rheumatology (Oxford); 2002 Sep; 41(9):988-95. PubMed ID: 12209031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
